Inhibition of LPS-induced cyclooxygenase 2 and nitric oxide production by transduced PEP-1-PTEN fusion protein in Raw 264.7 macrophage cells

Experimental and Molecular Medicine

Volumn 40, Issue 6, 2008, Pages 629-638

  Sun, Hwa Lee ^a   Yeom, Pyo Lee ^a   So, Young Kim ^a   Min, Seop Jeong ^a   Min, Jung Lee ^a   Hye, Won Kang ^a   Hoon, Jae Jeong ^a   Dae, Won Kim ^a   Eun, Joung Sohn ^a   Sang, Ho Jang ^a   Yeon, Hyang Kim ^a   Hyung, Joo Kwon ^a   Cho, Sung Woo ^b   Park, Jinseu ^a   Won, Sik Eum ^a   Soo, Young Choi ^a  

^a Hallym University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Cyclooxygenase 2; Inflammation; Lipopolysaccharides; Nitric oxide; PTEN phosphohydrolase

Indexed keywords

CYCLOOXYGENASE 2; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; LYSYLGLUTAMYLTHREONYLTRYPTOPHYLTRYPTOPHYLGLUTAMYLTHREONYLTRYPTOPHYL TRYPTOPHYLTHREONYLGLUTAMYLTRYPTOPHYLSERYLGLUTAMINYLPROLYLLYSYLLYSYLLYSYL ARGINYLLYSYLVALINE-PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE FUSION PROTEIN; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GENE FUSION; GENETIC TRANSFECTION; GENETICS; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN STABILITY;

BACTERIA (MICROORGANISMS);

EID: 61849093164     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2008.40.6.629     Document Type: Article

References (49)

1. Adams DO, Hamilton TA. The cell biology of macrophage activation. Annu Rev Immunol 1984;2:283-318
2. An JJ, Kim SY, Lee SH, Kim DW, Ryu HJ, Yeo SI, Jang SH, Kwon HJ, Kim TY, Lee SC, Poo H, Cho SW, Lee KS, Park J, Eum WS, Choi SY. Transduced PEP-1-Grb7 fusion protein suppressed LPS-induced COX-2 expression. J Biochem Mol Biol 2007;40:189-95
3. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-71
4. Bousquet J, Jeffery PK, Busse WW, Johnosn M, Vignola AM. Asthma: from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720-45
5. Bradford MA. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54
6. Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci USA 1999;96:4240-5
7. Carey MA, Germolec DR, Langenbach R, Zeldin DC. Cyclooxygenase enzymes in allergic inflammation and asthma. Prostaglandins Leukotrienes Essential Fatty Acids 2003;69:157-62
8. Choi HS, An JJ, Kim SY, Lee SH, Kim DW, Yoo KY, Won MH, Kang TC, Kwon HJ, Kang JH, Cho SW, Kwon OS, Park J, Eum WS, Choi SY. PEP-1-SOD fusion protein efficiently protects against paraquat-induced dopaminergic neuron damage in a Parkinson disease mouse model. Free Radic Biol Med 2006a;41:1058-68
9. Choi HS, Lee SH, Kim SY, An JJ, Hwang SI, Kim DW, Yoo KY, Won MH, Kang TC, Kwon HJ, Kang JH, Cho SW, Kwon OS, Choi JH, Park J, Eum WS, Choi SY. Transduced Tat-α-synuclein protects against oxidative stress in vitro and in vivo. J Biochem Mol Biol 2006b;39:253-62
10. Choi SH, Kim DW, Kim SY, An JJ, Lee SH, Choi HS, Sohn EJ, Hwang SI, Won MH, Kang TC, Kwon HJ, Kang JH, Cho SW, Park J, Eum WS, Choi SY. Transduced human copper chaperone for Cu,Zn-SOD (PEP-1-CCS) protects against neuronal cell death. Mol Cells 2005;20:401-8
11. Dunzendorfer S, Meierhofer C, Wiedermann CJ. Signaling in neuropeptide-induced migration of human eosinophils. J Leukoc Biol 1998;64:823-34
12. Eum WS, Choung IS, Kim AY, Lee YJ, Kang JH, Park J, Lee KS, Kwon HY, Choi SY. Transduction efficacy of Tat-superoxide dismutase is enhanced by copper ion recovery of the fusion protein. Mol Cells 2002;13:334-40
13. Eum WS, Choung IS, Li MZ, Kang J H, Kim DW, Park J, Kwon HY, Choi SY. HIV-1 Tat-mediated protein transduction of Cu,Zn-superoxide dismutase into pancreatic beta cells in vitro and in vivo. Free Radic Biol Med 2004a;37:339-49
14. Eum W S, Kim DW, Hwang IK, Yoo KY, Kang TC, Jang SH, Choi HS, Choi SH, Kim YH, Kim SY, Kwon HY, Kang JH, Kwon OS, Cho SW, Lee KS, Park J, Won MH, Choi SY. In vivo protein transduction: Biologically active intact PEP-1-superoxide dismutase fusion protein efficiently protects against ischemic insult. Free Radic Biol Med 2004b;37:1656-69
15. Frigas E, Gleich GI. The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol 1986;77:527-37
16. Fugihara S, Ward C, Dransfield I, Hay RT, Uings IJ, Hayes B, Farrow SN, Haslett C, Rossi AG. Inhibition of nuclear factor-kappaB activation un-masks the ability of TNF-alpha to induce human eosinophil apoptosis. Eur J Immunol 2002;32:457-66
17. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000;105:651-63
18. Kim DW, Kim CK, Choi SH, Choi HS, Kim SY, An JJ, Lee SR, Lee SH, Kwon OS, Kang TC, Won MH, Cho YJ, Cho SW, Kang JH, Kim TY, Lee KS, Park J, Eum WS, Choi SY. Tat-mediated protein transduction of human brain pyridoxal kinase into PC12 cells. Biochimie 2005;87:481-7
19. Kim JB, Han AR, Park, EY, Kim JY, Cho W, Lee J, Seo EK, Lee KT. Inhibition of LPS-induced iNOS, COX-2 and cytokines expression by poncirin through the NF-κB inactivation in Raw 264.7 macrophage cells. Biol Pharm Bull 2007;30:2345-51
20. Kim SY, An JJ, Kim DW, Choi SH, Lee SH, Hwang SI, Kwon OS, Kang TC, Won MH, Cho SW, Park J, Eum WS, Lee KS, Choi SY. Tat-mediated protein transduction of human pyridoxine-5-P oxidase into PC12 cells. J Biochem Mol Biol 2006;39:76-83
21. Kwak YG, Song CH, Yi HK, Hwang PH, Kim JS, Lee KS, Lee YC. Involvement of PTEN in airway hyperresopnsiveness and inflammation in bronchial asthma. J Clin Invest 2003;111:1083-92
22. Lee TH, Kwak HB, Kim HH, Lee ZH, Chung DK, Baek NI, Kim J. Methanol extracts of stewartia koreana inhibit cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) gene expression by blocking NF-κB transactivation in LPS-activated Raw 264.7 cells. Mol Cells 2007;23:398-404
23. Lee YP, Kim DW, Lee MJ, Jeong MS, Kim SY, Lee SH, Jang SH, Park J, Kang TC, Won MH, Cho SW, Kwon OS, Eum WS, Choi SY. Human brain pyridoxal-5′- phosphate phosphatase (PLPP): protein transduction of PEP-1-PLPP into PC12 cells. BMB Rep 2008;41:408-13
24. Li J, Yen C, Liaw K, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodger L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh, H, Wigler MH, Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275:1943-47
25. Lu Y, Lin YZ, LaPushin R, Cuevas B, Fang X, Yu SX, Davies MA, Khan H, Furui T, Mao M, Zinner R, Hung MC, Steck P, Siminovitch K, Mills GB. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene 1999;18:7034-45
26. Maehama T, Dixon JE. PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate. J Biol Chem 1998;273:13375-8
27. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 1993;214:11-6
28. Morris MC, Depollier J, Mery J, Heitz F, Divita G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 2001;19:1173-6
29. Morrison DC, Ryan JL. Endotoxins and disease mechanisms. Annu Rev Med 1987;38: 417-32
30. Myers MP, Pass I, Batty IH, van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK. The lipid phosphatase activity of PTEIN is critical for its tumor suppressor function. Proc Natl Acad Sci USA 1998;95:13513-8
31. Palframan RT, Collins PD, Severs NJ, Rothery S, Williams YJ, Rankin SM. Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase. J Exp Med 1998;188:1621-32
32. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, Zahringer U, Seydel U, Di Padova F. Bacterial endotoxin: molecular relationships and structure to activity and function. FASEB J 1994;8:217-25
33. Romanovsky AA, Ivanov AI, Petresen SR. Microsomal prostaglandin E synthase-1, ephrins, and ephrin kinases as suspected therapeutic targets in arthritis. Ann N Y Acad Sci 2006;1069:183-94
34. Simon LS. Actions and toxicity of nonsteroidal anti-inflammatory drugs. Curr Opin Rheumatol 1996;8:169-75
35. Smith WL, Dewit DL. Prostaglandin endoperoxide H synthase-1 and -2. Adv Immunol 1990;62:167-215
36. Song HY, Ju SM, Lee JA, Kwon HJ, Eum WS, Jang SH, Choi SY, Park J. Suppression of HIV-1 Tat-induced monocyte adhesiveness by a cell-permeable superoxide dismutase in astrocytes. Exp Mol Med 2007;39:778-86
37. Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF, Tavtigian SV. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997;15:356-62
38. Suzuki A, Tsukio-Yamaguchi M, Ohteki T, Sasaki T, Kaisho T, Kimura Y, Yoshida R, Wakeham A, Higuchi T, Fukumoto M, Tsubata T, Ohashi PS, Koyasu S, Penninger JM, Nakano T, Mak TW. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 2001;14:523-34
39. Suzuki A, Kaisho T, Ohishi M, Tsukio-Yamaguchi M, Tsubata T, Koni PA, Sasaki T, Mak TW, Nakano T. Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination. J Exp Med 2003a;197:657-67
40. Suzuki A, Itami S, Ohishi M, Hamada K, Inoue T, Komazawa N, Senoo H, Sasaki T, Takeda J, Manabe M, Mak TW, Nakano T. Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation. Cancer Res 2003b;63:674-81
41. Tigani B, Hannon JP, Mazzoni L, Fozard JR. Effects of wortmannin on airways inflammation induced by allergen in actively sensitized Brown Norway rats. Eur J Pharmacol 2001;433:217-23
42. Tilley SL, Coffman TM, Koller BA. Mixed message: gene: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 2001;107:191-5
43. Vancheri C, Mastruzzo C, Sortino MA, Crimi N. The lung as a privileged site for the beneficial actions of PEG2. Trends Immunol 2004;25:40-6
44. Vazquez F, Sellers WR. The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling. Biochim Biophys Acta 2000;1470:M21-M35
45. Wadia J, Dowdy SF. Protein transduction technology. Curr Opin Biotechnol 2002;13:52-6
46. Wong CK, Zhang JP, Ip WK, Lam CW. Activation of p38 mitogen-activated protein kinase and nuclear factor-kappaB in tumour necrosis factor-induced eotaxin release of human eosinophils. Clin Exp Immunol 2002;128:483-9
47. Yamada KM, Araki M. Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. J Cell Sci 2001;114:2375-82
48. Yun KJ, Kim JY, Kim JB, Lee KW, Jeong SY, Park HJ, Jung HJ, Cho YW, Yun K, Lee KT. Inhibition of LPS-induced NO and PGE2 production by asiatic acid via NF-κB inactivation in Raw 264.7 macrophages: Possible involvement of the IKK and MAPK pathways. Int Immunopharmacol 2008;8:431-41
49. Zhang SY, Park KW, Oh S, Cho HJ, Cho HJ, Park JS, Cho YS, Koo BK, Chae IH, Choi DJ, Kim HS, Lee MM. NF-kappaB decoy potentiates the effects of radiation on vascular smooth muscle cell by enhancing apoptosis. Exp Mol Med 2005;37:18-26